PUBLICACIÓN

Impact of current influenza vaccination recommendations in risk groups

Logo Open Access

ACCEDER A LA PUBLICACIÓN: Scopus Dialnet

2024 MEDICINA CLINICA

Medicine (miscellaneous) (Q3)

JCR: 2.1

SJR: 0.383

CITAS

1

DOI

10.1016/j.medcli.2023.10.022

EID

2-s2.0-85186923191

ISSN

0025-7753

EISSN

1578-8989

AUTORES DE LA UEX

Ana María Grande Tejada

OTRAS PUBLICACIONES DE INTERÉS

Early Response To Idursulfase Treatment In A 3 Year-Old Boy Affected Of Hunter Syndrome
Antiviral Treatment And Risk Of Hearing Loss In Asymptomatic And Mild Symptomatic Infants With Congenital Cytomegalovirus
Impact Of Current Influenza Vaccination Recommendations In Risk Groups
Antiviral Treatment And Risk Of Hearing Loss In Asymptomatic And Mild Symptomatic Infants With Congenital Cytomegalovirus
Impact Of Current Influenza Vaccination Recommendations In Risk Groups
Vaccination Schedule For Adolescents. Consensus Of The Aev, Cav-Aep And Sema
Impact Of Current Influenza Vaccination Recommendations In Risk Groups
Vaccination Schedule For Adolescents. Consensus Of The Aev, Cav-Aep And Sema
Pleural Effusion In A Child With A Correctly Placed Ventricle-Peritoneal Shunt
Vaccination Schedule For Adolescents. Consensus Of The Aev, Cav-Aep And Sema
Pleural Effusion In A Child With A Correctly Placed Ventricle-Peritoneal Shunt
Epidemiology, Prevention And Control Of Pertussis In Spain: New Vaccination Strategies For Lifelong Protection
Pleural Effusion In A Child With A Correctly Placed Ventricle-Peritoneal Shunt
Epidemiology, Prevention And Control Of Pertussis In Spain: New Vaccination Strategies For Lifelong Protection
Recovering Lost Vaccine Coverage Due To Covid-19 Pandemic
Epidemiology, Prevention And Control Of Pertussis In Spain: New Vaccination Strategies For Lifelong Protection
Recovering Lost Vaccine Coverage Due To Covid-19 Pandemic
Management And Monitoring Of Patients With Duchenne Disease
Recovering Lost Vaccine Coverage Due To Covid-19 Pandemic
Management And Monitoring Of Patients With Duchenne Disease
Erratum: Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs (Vacunas (2015) 16, 1:6-11))
Management And Monitoring Of Patients With Duchenne Disease
Erratum: Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs (Vacunas (2015) 16, 1:6-11))
Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs
Erratum: Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs (Vacunas (2015) 16, 1:6-11))
Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs
Safety And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Infants: A Meta-Analysis
Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs
Safety And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Infants: A Meta-Analysis
Assessment Of The Mf59-Adjuvanted Pandemic Influenza A/h1n1 Vaccine. Systematic Review Of Literature
Safety And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Infants: A Meta-Analysis
Assessment Of The Mf59-Adjuvanted Pandemic Influenza A/h1n1 Vaccine. Systematic Review Of Literature
Early Response To Idursulfase Treatment In A 3 Year-Old Boy Affected Of Hunter Syndrome
Assessment Of The Mf59-Adjuvanted Pandemic Influenza A/h1n1 Vaccine. Systematic Review Of Literature
Early Response To Idursulfase Treatment In A 3 Year-Old Boy Affected Of Hunter Syndrome
Antiviral Treatment And Risk Of Hearing Loss In Asymptomatic And Mild Symptomatic Infants With Congenital Cytomegalovirus
WEB ACCESIBLE